Stock Research for MNK

Featured Broker: Ally Invest

Get the due diligence for another stock.


MNK Stock Chart & Research Data

The MNK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MNK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MNK Due diligence Resources & Stock Charts

The MNK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MNK Detailed Price Forecast - CNN Money CNN View MNK Detailed Summary - Google Finance
Yahoo View MNK Detailed Summary - Yahoo! Finance Zacks View MNK Stock Research & Analysis -

Stock Analysis

TradeIdeas View MNK Trends & Analysis - Trade-Ideas Barrons View MNK Major Holders - Barrons
NASDAQ View MNK Call Transcripts - NASDAQ Seeking View MNK Breaking News & Analysis - Seeking Alpha
Spotlight View MNK Annual Report - OTC Report View MNK OTC Short Report -
TradeKing View MNK Fundamentals - TradeKing Charts View MNK SEC Filings - Bar Chart
WSJ View Historical Prices for MNK - The WSJ Morningstar View Performance/Total Return for MNK - Morningstar
MarketWatch View the Analyst Estimates for MNK - MarketWatch CNBC View the Earnings History for MNK - CNBC
StockMarketWatch View the MNK Earnings - StockMarketWatch MacroAxis View MNK Buy or Sell Recommendations - MacroAxis
Bullish View the MNK Bullish Patterns - American Bulls Short Pains View MNK Short Pain Metrics -

Social Media Mentions

StockTwits View MNK Stock Mentions - StockTwits PennyStocks View MNK Stock Mentions - PennyStockTweets
Twitter View MNK Stock Mentions - Twitter Invest Hub View MNK Investment Forum News - Investor Hub
Yahoo View MNK Stock Mentions - Yahoo! Message Board Seeking Alpha View MNK Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MNK - Insider Cow View Insider Transactions for MNK - Insider Cow
CNBC View MNK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MNK - OTC Markets
Yahoo View Insider Transactions for MNK - Yahoo! Finance NASDAQ View Institutional Holdings for MNK - NASDAQ

Stock Charts

FinViz View MNK Stock Insight & Charts - StockCharts View MNK Investment Charts -
BarChart View MNK Stock Overview & Charts - BarChart Trading View View MNK User Generated Charts - Trading View

Latest Financial News for MNK

Mallinckrodt plc To Report Earnings Results For Second Quarter Of Fiscal 2018
Posted on Friday June 22, 2018

Callers will need to provide the Conference ID of 8438559. All callers will be required to provide the Conference ID of 8438559. Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies.

Mallinckrodt Launches Scientific Advisory Council
Posted on Thursday June 21, 2018

-- Leading experts named to provide scientific guidance to company's R&D and portfolio strategy -- STAINES-UPON-THAMES, United Kingdom , June 21, 2018 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading ...

Report: Exploring Fundamental Drivers Behind Tile Shop Holdings, Anworth Mortgage Asset, Advanced Disposal Services, PacWest, Workday, and Mallinckrodt — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Monday June 18, 2018

NEW YORK, June 18, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tile ...

Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel (Repository Corticotropin Injection) Studies
Posted on Monday June 18, 2018

STAINES-UPON-THAMES, United Kingdom, June 18, 2018 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, recently reported preliminary interim data from ongoing H.P. Acthar® Gel (repository corticotropin injection) studies, including the company's Phase 4 Rheumatoid Arthritis (RA) clinical trial and its prospective observational registry for Multiple Sclerosis (MS) relapse. Details on both the RA (available here) and MS (available here) data presentations were posted to Mallinckrodt's website.

Enter a stock symbol to view the stock details.